A Magnetic-Responsive Biomimetic Nanosystem Coated with Glioma Stem Cell Membranes Effectively Targets and Eliminates Malignant Gliomas

Overview

Journal Biomater Res

Specialty Biomedical Engineering

Date 2024 Dec 30

PMID 39735729

Authors

Song Deng

Dekang Nie

Yue Huang

Yu Yang

Qianqian Liu

Zesheng Sun

Qiaoji Jiang

Yuejuan Ling

Ya Wen

Jiahua Qu

Jialiang Lin

Yi Wang

Rongqin Huang

Jinlong Shi

Affiliations

Soon will be listed here.

Abstract

Glioblastoma multiforme (GBM) is among the most challenging malignant brain tumors, making the development of new treatment strategies highly necessary. Glioma stem cells (GSCs) markedly contribute to drug resistance, radiation resistance, and tumor recurrence in GBM. The therapeutic potential of nanomaterials targeting GSCs in GBM urgently needs to be explored. A magnetic-responsive biomimetic nanosystem (FDPM), coated with glioma stem cell membranes (CMs), was designed for the targeted eradication of GSCs as well as their associated tumor cells. Identified nanobodies were extensively characterized with various assays. The application tests on nanomaterials were conducted in vitro and in vivo. The tumor-suppressive effects of the nanosystem were evaluated in vitro and in vivo. FDPM can be artificially directed under magnetic guidance while inheriting various biological functions from CM. Upon intravenous injection, FDPM was drawn to the tumor site by magnetic attraction, where it could cross the blood-brain barrier aided by CM. Its homologous targeting ability originates from active proteins on CM, enabling it to specifically target GSCs and related tumor cells. The encapsulated doxorubicin (DOX) within the nanoparticle then destroyed these tumor cells. FDPM demonstrated excellent biocompatibility and tumor-targeting efficiency, effectively targeting malignant gliomas initiated by GSCs. FDPM significantly reduced tumor cells, inhibited tumor growth, and notably extended the survival of glioma-bearing nude mice. The findings position FDPM as a promising nanoplatform to target GSCs and related tumor cells for improving the therapeutic effect of glioma.

References

Li S, Cheng H, Xie B, Qiu W, Zeng J, Li C . Cancer Cell Membrane Camouflaged Cascade Bioreactor for Cancer Targeted Starvation and Photodynamic Therapy. ACS Nano. 2017; 11(7):7006-7018. DOI: 10.1021/acsnano.7b02533. View

Fang R, Gao W, Zhang L . Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat Rev Clin Oncol. 2022; 20(1):33-48. DOI: 10.1038/s41571-022-00699-x. View

Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S . Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell. 2009; 15(6):501-13. PMC: 2693960. DOI: 10.1016/j.ccr.2009.03.018. View

Zhu Z, Amir Khan M, Weiler M, Blaes J, Jestaedt L, Geibert M . Targeting self-renewal in high-grade brain tumors leads to loss of brain tumor stem cells and prolonged survival. Cell Stem Cell. 2014; 15(2):185-98. DOI: 10.1016/j.stem.2014.04.007. View

Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon R . Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res. 2008; 68(15):6043-8. PMC: 2739001. DOI: 10.1158/0008-5472.CAN-08-1079. View

Xie X, Jiang K, Li B, Hou S, Tang H, Shao B . A small-molecule self-assembled nanodrug for combination therapy of photothermal-differentiation-chemotherapy of breast cancer stem cells. Biomaterials. 2022; 286:121598. DOI: 10.1016/j.biomaterials.2022.121598. View

Sharifzad F, Ghavami S, Verdi J, Mardpour S, Sisakht M, Azizi Z . Glioblastoma cancer stem cell biology: Potential theranostic targets. Drug Resist Updat. 2019; 42:35-45. DOI: 10.1016/j.drup.2018.03.003. View

Singh S, Hawkins C, Clarke I, Squire J, Bayani J, Hide T . Identification of human brain tumour initiating cells. Nature. 2004; 432(7015):396-401. DOI: 10.1038/nature03128. View

Jia Y, Wang X, Hu D, Wang P, Liu Q, Zhang X . Phototheranostics: Active Targeting of Orthotopic Glioma Using Biomimetic Proteolipid Nanoparticles. ACS Nano. 2018; 13(1):386-398. DOI: 10.1021/acsnano.8b06556. View

10.

Wang Z, Liang P, He X, Wu B, Liu Q, Xu Z . Etoposide loaded layered double hydroxide nanoparticles reversing chemoresistance and eradicating human glioma stem cells in vitro and in vivo. Nanoscale. 2018; 10(27):13106-13121. DOI: 10.1039/c8nr02708k. View

11.

Zhang Z, Guan J, Jiang Z, Yang Y, Liu J, Hua W . Brain-targeted drug delivery by manipulating protein corona functions. Nat Commun. 2019; 10(1):3561. PMC: 6687821. DOI: 10.1038/s41467-019-11593-z. View

12.

Bao S, Wu Q, McLendon R, Hao Y, Shi Q, Hjelmeland A . Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444(7120):756-60. DOI: 10.1038/nature05236. View

13.

Sun H, Su J, Meng Q, Yin Q, Chen L, Gu W . Cancer-Cell-Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumors. Adv Mater. 2016; 28(43):9581-9588. DOI: 10.1002/adma.201602173. View

14.

Chai Z, Ran D, Lu L, Zhan C, Ruan H, Hu X . Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma. ACS Nano. 2019; 13(5):5591-5601. DOI: 10.1021/acsnano.9b00661. View

15.

Chojnacki A, Weiss S . Production of neurons, astrocytes and oligodendrocytes from mammalian CNS stem cells. Nat Protoc. 2008; 3(6):935-40. DOI: 10.1038/nprot.2008.55. View

16.

Galdieri L, Jash A, Malkova O, Mao D, DeSouza P, Chu Y . Defining phenotypic and functional heterogeneity of glioblastoma stem cells by mass cytometry. JCI Insight. 2021; 6(4). PMC: 7934942. DOI: 10.1172/jci.insight.128456. View

17.

Kauer T, Figueiredo J, Hingtgen S, Shah K . Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas. Nat Neurosci. 2011; 15(2):197-204. PMC: 3601490. DOI: 10.1038/nn.3019. View

18.

Cui Q, Yang S, Ye P, Tian E, Sun G, Zhou J . Downregulation of TLX induces TET3 expression and inhibits glioblastoma stem cell self-renewal and tumorigenesis. Nat Commun. 2016; 7:10637. PMC: 4742843. DOI: 10.1038/ncomms10637. View

19.

Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T . Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature. 2010; 468(7325):824-8. DOI: 10.1038/nature09557. View

20.

. Pinpointing Cancer Stem Cells in Oligodendroglioma. Cancer Discov. 2016; 7(1):6. DOI: 10.1158/2159-8290.CD-NB2016-149. View